Rare lung diseases I--Lymphangioleiomyomatosis.

Rare lung diseases I--Lymphangioleiomyomatosis.

The present article is the first in a series that will review selected rare lung diseases. The objective of this series is to promote a greater understanding and awareness of these unusual conditions among respirologists. Each article will begin with a case that serves as a focal point for a discuss...

Полное описание

Библиографические подробности
Главные авторы:	Juvet, S, Hwang, D, Downey, G
Формат:	Journal article
Язык:	English
Опубликовано:	2006

Схожие документы

Rare Lung Diseases I – Lymphangioleiomyomatosis
по: Stephen C Juvet, и др.
Опубликовано: (2006-01-01)

Rare lung disease II: pulmonary alveolar proteinosis.
по: Juvet, S, и др.
Опубликовано: (2008)

Rare Lung Diseases III: Pulmonary Langerhans’ Cell Histiocytosis
по: Stephen C Juvet, и др.
Опубликовано: (2010-01-01)

Rare Lung Diseases II: Pulmonary Alveolar Proteinosis
по: Stephen C Juvet, и др.
Опубликовано: (2008-01-01)

Lung Transplantation for Lymphangioleiomyomatosis in Japan.
по: Katsutoshi Ando, и др.
Опубликовано: (2016-01-01)

Repurposing Nitazoxanide for Potential Treatment of Rare Disease Lymphangioleiomyomatosis
по: Stella Bähr, и др.
Опубликовано: (2024-09-01)

A case of lymphangioleiomyomatosis of the lungs
по: S I Ovcharenko, и др.
Опубликовано: (2004-03-01)

Canadian Respirologists’ Experience with Lymphangioleiomyomatosis
по: Stacey M Pollock-BarZiv, и др.
Опубликовано: (2002-01-01)

The lung microbiome in end-stage Lymphangioleiomyomatosis
по: Julie Ng, и др.
Опубликовано: (2021-10-01)

A rare case of lymphangioleiomyomatosis with recurrent pneumothorax
по: Vinay Mahishale, и др.
Опубликовано: (2015-01-01)

Pulmonary Lymphangioleiomyomatosis and Role of Pleurodesis: Rare Case Reports
по: KUSUM V SHAH, и др.
Опубликовано: (2021-03-01)

Evolution of lung pathology in lymphangioleiomyomatosis: associations with disease course and treatment response
по: Suzanne Miller, и др.
Опубликовано: (2020-07-01)

The value of transbronchial lung biopsy in the diagnosis of lymphangioleiomyomatosis
по: Wenshuai Xu, и др.
Опубликовано: (2021-05-01)

Effects of sirolimus on Lung function in patients with Lymphangioleiomyomatosis
по: Fatemeh Aghaeimeybodi, и др.
Опубликовано: (2019-01-01)

Difficult diagnosis and rare morphology of lymphangioleiomyomatosis with giant cysts
по: Stefan Welter, и др.
Опубликовано: (2019-01-01)

Computer grading of lung disease severity in patients with lymphangioleiomyomatosis referred for transplantation
по: Angelo M. Taveira-DaSilva, и др.
Опубликовано: (2022-09-01)

Lung Transplantation Outcomes and Peritransplant Sirolimus Use in Lymphangioleiomyomatosis
по: Emily L. Larson, BS, и др.
Опубликовано: (2025-03-01)

Multiple Cysts in the Kidney and Lungs in a Patient with Polycystic Kidney Disease and Lymphangioleiomyomatosis
по: Anna P. Lam, и др.
Опубликовано: (2007-01-01)

Dysregulated lipid metabolism in lymphangioleiomyomatosis pathogenesis as a paradigm of chronic lung diseases
по: Clara Bernardelli, и др.
Опубликовано: (2023-01-01)

Extrapulmonary manifestation of lymphangioleiomyomatosis.
по: N. Favoreel, и др.
Опубликовано: (2015-02-01)

Chylothorax, in the Spotlight of Lymphangioleiomyomatosis
по: Pablo Gámez-Baeza, и др.
Опубликовано: (2022-10-01)

Methylprednisolone in the treatment of lymphangioleiomyomatosis
по: Ventour Dale, и др.
Опубликовано: (2022-05-01)

Treatment of lymphangioleiomyomatosis and Camões
по: Rogério Rufino
Опубликовано: (2015-08-01)

Milestones in lymphangioleiomyomatosis research
по: V. Cottin, и др.
Опубликовано: (2011-03-01)

Pulmonary lymphangioleiomyomatosis (PLAM)
по: Verma S, и др.
Опубликовано: (2007-01-01)

Lymphangioleiomyomatosis with lung cancer: report of two cases and literature review
по: Zilinuer ABUDUXUKUER, и др.
Опубликовано: (2024-10-01)

Lymphangioleiomyomatosis Biomarkers Linked to Lung Metastatic Potential and Cell Stemness.
по: Gorka Ruiz de Garibay, и др.
Опубликовано: (2015-01-01)

Refractory chylous effusions in lymphangioleiomyomatosis patient post lung transplant
по: Samuel Jacob, и др.
Опубликовано: (2020-05-01)

Wild type mesenchymal cells contribute to the lung pathology of lymphangioleiomyomatosis.
по: Debbie Clements, и др.
Опубликовано: (2015-01-01)

Pulmonary lymphangioleiomyomatosis (case report)
по: Shashina M.M., и др.
Опубликовано: (2017-12-01)

Safe and effective use of nivolumab for treating lung adenocarcinoma associated with sporadic lymphangioleiomyomatosis: a rare case report
по: Johan Pluvy, и др.
Опубликовано: (2019-01-01)

Sporadic Lymphangioleiomyomatosis Disease: A Case Report
по: Yousef Nikmanesh, и др.
Опубликовано: (2023-09-01)

Efficacy and safety of low-dose Sirolimus in Lymphangioleiomyomatosis
по: Hee-Young Yoon, и др.
Опубликовано: (2018-11-01)

A Retrospective Study of Lung Transplantation in Patients With Lymphangioleiomyomatosis: Challenges and Outcomes
по: Ji Zhang, и др.
Опубликовано: (2021-02-01)

Correction: Lymphangioleiomyomatosis Biomarkers Linked to Lung Metastatic Potential and Cell Stemness.
по: Gorka Ruiz de Garibay, и др.
Опубликовано: (2018-01-01)

Quantitative analysis of computed tomography of the lungs in patients with lymphangioleiomyomatosis treated with sirolimus
по: Yuki Ko, и др.
Опубликовано: (2020-02-01)

Lymphangioleiomyomatosis of the lungs: features of the clinical picture, diagnosis and treatment. Case report
по: Galina L. Ignatova, и др.
Опубликовано: (2022-05-01)

Morphology of lungs in pulmonary lymphangioleiomyomatosis – A unique case of bilateral lungs and heart transplant
по: Shirish Sahebrao Chandanwale, и др.
Опубликовано: (2023-01-01)

The development for emerging biomarkers of lymphangioleiomyomatosis
по: Liting Huang, и др.
Опубликовано: (2024-11-01)

Dramatic Response to Sirolimus in Lymphangioleiomyomatosis
по: Dmitry Rozenberg, и др.
Опубликовано: (2013-01-01)